Table 2.
Obstetric, antenatal, intrapartum, and postpartum characteristics of the study population
| Characteristics | Categories | n (%) |
|---|---|---|
| Order of pregnancy | 1 | 42 (45.2) |
| 2 | 34 (36.6) | |
| ≥3 | 17 (18.2) | |
| Strong risk factors | No high risk | 81 (87.1) |
| Previous stillbirth/neonatal death | 07 (7.5) | |
| Previous cesarean section | 02 (2.2) | |
| Abnormal presentation | 01 (1.1) | |
| Previous preterm | 02 (2.2) | |
| Visits to antenatal clinic (n) | <3 | Nil |
| 3–5 | 10 (10.8) | |
| >5 | 83 (89.2) | |
| IFA tablets consumed during antenatal period (n) | <50 | 08 (8.9) |
| 51–100 | 13 (13.9) | |
| ≥100 | 72 (77.4) | |
| Place of delivery Perceived blood loss at time of delivery | Primary health center | 28 (30.1) |
| Higher center | 65 (69.8) | |
| Do not know | 05 (5.4) | |
| Mild | 20 (21.5) | |
| Moderate | 29 (31.2) | |
| Heavy | 39 (41.9) | |
| Consumption of FA tablets in postpartum period, days | Not taken at all | 36 (39.1) |
| 0–14 | 16 (17.2) | |
| 15–29 | 03 (3.3) | |
| ≥30 | 38 (40.7) | |
| Postnatal visits by any health worker | No visits at all | 05 (5.4) |
| 1 | 54 (58.1) | |
| 2 | 33 (35.5) | |
| >2 | 01 (1.1) |
Abbreviation: IFA, iron and folic acid.